Parallel (randomized) phase II evaluation of tivantinib (ARQ197) and tivantinib in combination with erlotinib in papillary renal cell carcinoma: SWOG S1107

Przemyslaw W. Twardowski, Catherine M. Tangen, Xiwei Wu, Melissa R. Plets, Elizabeth R. Plimack, Neeraj Agarwal, Nicholas J. Vogelzang, Jinhui Wang, Shu Tao, Ian M. Thompson, Primo Lara

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Parallel (randomized) phase II evaluation of tivantinib (ARQ197) and tivantinib in combination with erlotinib in papillary renal cell carcinoma: SWOG S1107'. Together they form a unique fingerprint.

Medicine & Life Sciences